Scott Lain

Scott supports consulting engagements with pharmaceutical manufacturers and health plans on topics such as market access, policy evaluation, and financial forecasting. Scott values an analytical approach to strategy and decision-making, specializing in the development of dynamic models and interactive tools.

Scott has led or supported a variety of projects on topics, including:

• Developing Medicare Part D strategy and tactics, including Inflation Reduction Act impact and strategic response
• Projecting cell and gene therapy utilization though clinical research and claims data analysis
• Consolidating data assets into dashboards and reporting tools to identify business risks and opportunities
• Assessing policy through qualitative and quantitative efforts to capture potential risks and impacts
• Developing and supporting multi-functional contracting models
• Supporting product launches through pricing, customer targeting, implementation, and pull-through activities
• Creating and facilitating training materials on topics such as Medicare, the Inflation Reduction Act, the product launch process, and others
• Developing infographics and whitepapers for use by advocacy and policy groups